ENGN Straddle Strategy
ENGN (enGene Holdings Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
ENGN (enGene Holdings Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $78.8M, a beta of -0.01 versus the broader market, a 52-week range of 1.4-12.25, average daily share volume of 1.2M, a public-listing history dating back to 2022, approximately 56 full-time employees. These structural characteristics shape how ENGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.01 indicates ENGN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on ENGN?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current ENGN snapshot
As of May 15, 2026, spot at $1.71, ATM IV 93.80%, expected move 26.89%. The straddle on ENGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on ENGN specifically: IV rank is unavailable in the current snapshot, so regime-based timing for ENGN is inferred from ATM IV at 93.80% alone, with a market-implied 1-standard-deviation move of approximately 26.89% (roughly $0.46 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ENGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on ENGN should anchor to the underlying notional of $1.71 per share and to the trader's directional view on ENGN stock.
ENGN straddle setup
The ENGN straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ENGN near $1.71, the first option leg uses a $1.71 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ENGN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ENGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.71 | N/A |
| Buy 1 | Put | $1.71 | N/A |
ENGN straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
ENGN straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on ENGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on ENGN
Straddles on ENGN are pure-volatility plays that profit from large moves in either direction; traders typically buy ENGN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
ENGN thesis for this straddle
The market-implied 1-standard-deviation range for ENGN extends from approximately $1.25 on the downside to $2.17 on the upside. A ENGN long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. As a Healthcare name, ENGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ENGN-specific events.
ENGN straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ENGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ENGN alongside the broader basket even when ENGN-specific fundamentals are unchanged. Always rebuild the position from current ENGN chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on ENGN?
- A straddle on ENGN is the straddle strategy applied to ENGN (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With ENGN stock trading near $1.71, the strikes shown on this page are snapped to the nearest listed ENGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ENGN straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the ENGN straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 93.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ENGN straddle?
- The breakeven for the ENGN straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ENGN market-implied 1-standard-deviation expected move is approximately 26.89%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on ENGN?
- Straddles on ENGN are pure-volatility plays that profit from large moves in either direction; traders typically buy ENGN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current ENGN implied volatility affect this straddle?
- Current ENGN ATM IV is 93.80%; IV rank context is unavailable in the current snapshot.